Senolytic Peptides and the Selectivity Test
A patent describes peptides intended to induce apoptosis in senescent cells, but the available excerpt does not establish whether experiments demonstrated selective killing.
Senolytic Peptides and the Selectivity Test
The patent publication “Novel senolytic peptides” describes peptides intended to trigger apoptosis in senescent cells. Apoptosis means programmed cell death; senescent cells are cells that have entered cellular senescence.
This aim matches the purpose of senolytics: selectively eliminating senescent cells while sparing non-senescent cells. However, the available excerpt does not establish whether experiments demonstrated that selectivity. Assessing it requires results from direct comparisons of the peptides' effects on senescent and non-senescent cells at the same concentrations. Whether the full document provides those results remains to be checked.
Sources
[1] WO2019069070A1 - Novel senolytic peptides - Google Patents
This connection gives readers a specific peptide approach to senolysis and a precise question for evaluating it: whether comparative experiments demonstrate selective killing of senescent cells.